GEBN:SIXGeberit AG Analysis
Data as of 2026-03-10 - not real-time
CHF 572.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Geberit AG trades at CHF 572, well above its 20‑day SMA of 625 and the 200‑day SMA of 614, while the RSI sits at a bearish 29, indicating oversold conditions. The MACD histogram is deeply negative and the signal line is bearish, suggesting short‑term momentum pressure despite a bullish trend direction flag. Fundamentally, the stock appears overvalued with a trailing P/E of 32.3 versus an industry average of 29.5, a P/B of 15.8, and a DCF fair‑value estimate of only CHF 251. Dividend yield remains attractive at 2.26%, but a 72% payout ratio combined with zero free cash flow and high debt (CHF 1.37 bn) raises sustainability concerns.
The building‑products sector is moderately cyclical, and Geberit’s global footprint introduces medium geographic and regulatory exposure, though its low beta (≈0.3) and increasing volume mitigate market risk. Given the mixed technical signals, overvalued valuation, and cash‑flow constraints, the near‑term outlook is neutral, the medium‑term view remains cautious, and the long‑term perspective leans toward a corrective sell stance.
The building‑products sector is moderately cyclical, and Geberit’s global footprint introduces medium geographic and regulatory exposure, though its low beta (≈0.3) and increasing volume mitigate market risk. Given the mixed technical signals, overvalued valuation, and cash‑flow constraints, the near‑term outlook is neutral, the medium‑term view remains cautious, and the long‑term perspective leans toward a corrective sell stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below short‑term moving averages
- RSI indicating oversold condition
- Bearish MACD histogram
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Overvalued valuation metrics (P/E, P/B)
- High debt level relative to equity
- Moderate sector cyclicality
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- DCF fair‑value far below market price
- Zero free cash flow and high payout ratio
- Potential correction from extreme greed market sentiment
Key Metrics & Analysis
Financial Health
Revenue Growth2.70%
Profit Margin18.86%
P/E Ratio32.3
Debt/Equity114.94
P/B Ratio15.8
Op. Cash FlowCHF867.6M
Industry P/E29.5
Technical Analysis
TrendBullish
RSI29.5
SupportCHF 559.60
ResistanceCHF 659.80
MA 20CHF 625.19
MA 50CHF 618.45
MA 200CHF 614.59
MACDBearish
VolumeIncreasing
Fear & Greed Index78.8
Valuation
Fair ValueCHF 251.05
Target PriceCHF 587.89
Upside/Downside2.78%
GradeOvervalued
TypeBlend
Dividend Yield2.26%
Risk Assessment
Beta0.29
Volatility23.91%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.